ALT SOLUTIONS INC has a total of 27 patent applications. Its first patent ever was published in 2005. It filed its patents most often in China, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are APODEMUS AB, PHOENIX BIOTECHNOLOGY INC and SYNVISTA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Canada | 4 | |
#4 | Japan | 4 | |
#5 | United States | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Foods and drinks | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Electrotherapy | |
#4 | Enzymes | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Microorganisms | |
#8 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bondarev Igor E | 19 |
#2 | Bertram John S | 5 |
#3 | Igor E Bondarev | 3 |
#4 | Bondarev Igor E Bertram John S | 1 |
#5 | Bondarev Igor | 1 |
Publication | Filing date | Title |
---|---|---|
EP2001488A2 | Prevention and treatment of cancer and other diseases | |
CN101443021A | Prevention and treatment of cancer and other diseases | |
CN101588805A | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer | |
CN104997783A | Modulation of telomere length in telomerase positive cells and cancer therapy | |
EP2623105A2 | Modulation of line-1 reverse transcriptase |